Why the Hesitancy in Recommending Combination T3/T4 Therapy?
This is a very good interview. The conclusion is combination T3/T4 therapy is preferred by most patients but if you are doing well on T4 only, probably best to stay with that for now. Slow-release T3 is nearing FDA approval. Studies show no difference in the lab work between combo therapy and T4 only, but patients generally prefer combo therapy. Also, combo therapy has no downside over T4 if TSH is monitored and kept within range. ABN
American Buddhist Net 